| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 07/09/2009 | WO2009085637A1 Amorphous metaxalone and amorphous dispersions thereof |
| 07/09/2009 | US20090176993 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism |
| 07/08/2009 | EP1836173A4 Anti-inflammatory medicaments |
| 07/08/2009 | CN101479238A Amine derivative having npyy5 receptor antagonist activity |
| 07/08/2009 | CN100510098C Optically active, heteroaromatic beta-hydroxy esters, processes for their preparation from beta-keto esters and processes for the preparation of these beta-keto esters |
| 07/07/2009 | US7557214 Intermediate products for producing oxazolidinone-quinolone hybrids |
| 07/07/2009 | CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 07/02/2009 | WO2009080788A2 Antibacterial agents |
| 07/02/2009 | WO2009080446A1 2-methylthioethyl-substituted heyrrocycles as feed additives |
| 07/02/2009 | WO2009061811A8 Substituted cyclopentanes having prostaglanding activity |
| 07/02/2009 | WO2009012201A3 Process for the preparation of trifluoroalkyl-phenyl and heterocyclic sulfonamides |
| 07/02/2009 | US20090170915 POLYMORPHIC FORMS OF (S)-1-cyanobutan-2-yl (S)-1-(3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)uriedo)phenyl)ethylcarbamate |
| 07/02/2009 | US20090170908 Spiro compounds and pharmaceutical use thereof |
| 07/02/2009 | US20090170883 3-arylphenyl sulfide derivative and insecticide and miticide |
| 07/02/2009 | US20090170864 (S)-3-{5-[(1-Pyridin-2-yl-3-trifluoromethyl-1H-pyrazole-4-carbonyl)-amino]-pyridin-2-ylamino}-pyrrolidine-1-carboxylic acid ethyl ester; obesity, type II diabetes mellitus and metabolic syndrome |
| 07/02/2009 | US20090170812 Transcription factor modulating compounds and methods of use thereof |
| 07/02/2009 | CA2710170A1 2-methylthioethyl-substituted heterocycles as feed additives |
| 07/01/2009 | EP2074089A2 Organic compounds |
| 07/01/2009 | EP1599455B1 4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis |
| 07/01/2009 | CN100506805C Process for producing 5-substituted oxa zole compounds and 5-substituted imidazole compounds |
| 07/01/2009 | CN100506788C Arylalkylcarbamate derivatives production and use thereof in therapy |
| 07/01/2009 | CN100506776C NK1 antagonists |
| 06/30/2009 | US7554000 Reacting an arylhydrazine, hydrogen peroxide and an aryl compound using a catalytic metal of Group 5,6,7 or 8 or an oxide of a metal of Group 5,6,7 or 8 obtained by reacting the given metal with hydrogen peroxide; improved yield; quaternary amine as phase transfer agent; water solvent and by-product |
| 06/30/2009 | US7553975 2-(((2-amino-1-oxo-3-mercapto-propyl)-amino)-methyl)-5-phenyl-thiazole-4-carbonyl-methionine; useful for treating restenosis or tissue proliferative diseases |
| 06/30/2009 | US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/30/2009 | US7553860 e.g.(S)-methyl 5-(((3-(4-(1-hydroxyhexyl)phenyl)-2-oxooxazolidin-4-yl)methoxy)methyl)thiophene-2-carboxylate; prostaglandin EP2 agonist; ocular hypotensive, antiinflammatory agent; glaucoma, inflammatory bowel disease and as presurgical adjuncts |
| 06/25/2009 | WO2009079597A1 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
| 06/25/2009 | WO2009079593A1 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
| 06/25/2009 | WO2009078813A1 Method of forming oseltamivir and derivatives thereof |
| 06/25/2009 | WO2009043027A3 Multi-armed forms of activated polyoxazoline and methods of synthesis thereof |
| 06/25/2009 | WO2008152306A3 Novel peptidase substrates |
| 06/25/2009 | WO2008098396A3 Oxazolidinones and their use as hypocholesterolemic agents |
| 06/25/2009 | US20090163561 Amorphous metaxalone and amorphous dispersions thereof |
| 06/25/2009 | US20090163549 Pharmaceutical Composition Comprising an Amide Derivative |
| 06/25/2009 | US20090163496 Antibacterial agents |
| 06/25/2009 | US20090163485 Heteroaryl derivatives as orexin receptor antagonists |
| 06/25/2009 | US20090162474 2-methylthioethyl-substituted heterocycles as feed additives |
| 06/25/2009 | DE102007062199A1 2-Methylthioethyl-substituierte Heterocyclen als Futtermitteladditive 2-methylthioethyl-substituted heterocycles as feed additives |
| 06/25/2009 | DE102007061630A1 Preparing montelukast sodium, useful e.g. to antagonize leukotriene, comprises reacting sodium alkoxide compound with montelukast acid in organic solvent, where the montelukast acid is obtained by acidifying montelukast cyclohexylamine |
| 06/24/2009 | EP2072505A2 A process for the preparation of oxazolidinone derivatives |
| 06/24/2009 | EP1620093B1 Pesticidal (dihalopropenyl) phenylalkyl substituted benzoxazole and benzothiazole derivatives |
| 06/24/2009 | CN101466688A Oxazole derivatives and their use in the treatment of diabetes and obesity |
| 06/24/2009 | CN101466687A Activating agent for peroxisome proliferator activated receptor delta |
| 06/24/2009 | CN100503600C Pesticidal heterocycles |
| 06/24/2009 | CN100503568C Process for the preparation of perindopril, its analgous compounds and salts therof using 2,5 dioxo-oxazolidine intermediate compounds |
| 06/23/2009 | USRE40795 Pesticides, drugs, fungicides; reacting p-toluenesulfony isocyanate with phosphorus oxychloride or phosgene in presence of phase transfer agent and base; final stable solution without irritating, nonexplosive |
| 06/23/2009 | US7550511 amino alcohols; selective ribonucleic acid (RNA) binding agents; detecting the binding of small molecules to T-box antiterminator model mRNAs; screening for microbiocidal drug targets; use disinfecting; antiviral, anti-HIV; e.g. use of 1,2-dihydroxy-3-amino-4-phenylbutane |
| 06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 06/23/2009 | US7550448 Therapeutic compounds |
| 06/18/2009 | WO2009075080A1 Fluoroalkylsulfide derivative and pest control agent |
| 06/18/2009 | WO2009046841A3 Piperidine and piperazine derivatives for treating tumours |
| 06/18/2009 | US20090156828 Novel Compounds and Methods for Forming Taxanes and Using the Same |
| 06/18/2009 | US20090156807 Anti-tumor Compounds Derived From 1,4,5,8-tetrachloroanthraquinone |
| 06/18/2009 | US20090156653 such as 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentane-1-ol, used for treating autoimmune diseases, rheumatoid arthritis, psoriasis, dermatitis, asthma, hay fever or rejection of organ or bone morrow transplantation; side effect reduction |
| 06/18/2009 | US20090156640 Nociceptin analogs |
| 06/18/2009 | US20090156590 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process for Making Them, and Use Thereof for Treating Pain and Other Conditions |
| 06/18/2009 | US20090156588 such as 3-[4-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-7-hydroxy-3,4-dihydro-benzo[e][1,3]oxazin-2-one, inhibitors macrophage migration inhibitory factor isomerase activity; treatment of vision defects, ischemia, inflammatory, autoimmune, bone, nervous system, cardiovascular and gastrointestinal disorders |
| 06/18/2009 | US20090156556 Aminopropanol derivatives |
| 06/17/2009 | EP1611088B1 Hydroxamates as therapeutic agents |
| 06/17/2009 | EP1357115B1 Alkanoic acid derivatives, process for their production and use thereof |
| 06/17/2009 | CN101460469A Chemical compounds |
| 06/16/2009 | US7547790 Optically active 4,4-di-substituted oxazolidine derivative and method for producing same |
| 06/16/2009 | US7547711 Heterocyclic inhibitors of kinases |
| 06/11/2009 | WO2009073713A1 Oximyl macrocyclic derivatives |
| 06/11/2009 | WO2008152305A3 Novel nitroreductase enzymatic substrates |
| 06/11/2009 | WO2007083320A3 Conversion of aromatic diazonium salt to aryl hydrazine |
| 06/11/2009 | US20090149657 Process for the synthesis of intermediates of chloramphenicol or its analogues |
| 06/11/2009 | US20090149520 Oxazolidinones containing oxindoles as antibacterial agents |
| 06/11/2009 | US20090149519 Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments |
| 06/11/2009 | US20090149445 Tricyclic steroid hormone nuclear receptor modulators |
| 06/11/2009 | US20090149425 Malononitrile compound as pesticides |
| 06/10/2009 | EP2066647A1 Benzoxazoles and oxazolopyridines being useful as janus kinases inhibitors |
| 06/10/2009 | EP2066632A1 Benzophenone derivatives useful for inhibiting formation of microtubule |
| 06/10/2009 | CN101454299A Ureide derivative and use thereof for medical purposes |
| 06/10/2009 | CN100497323C New heterocyclic oxime compounds, preparing process and medical composition thereof |
| 06/09/2009 | US7544809 Peroxisome proliferator activated receptor agonists |
| 06/09/2009 | US7544687 (2S)-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)-ethoxy]-phenyl}-2-(4-m-tolyl-piperazin-1-yl)-propionic acid; hyperglycemia, dyslipidemia, type II diabetes mellitus; (2S)-2-[4-(4-nitro-benzenesulfonyl)-piperazin-1-yl]-3-{4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)-ethoxy]-phenyl}-propionic acid; |
| 06/04/2009 | US20090143353 Antifungal bicyclic hetero ring compounds |
| 06/03/2009 | EP2064195A2 Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol and pharmaceutical formulations thereof |
| 06/03/2009 | EP1786790B1 Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses |
| 06/03/2009 | CN101445490A Method for preparing optically pure L-goitrin and D-goitrin by adopting liquid chromatogram and chiral separation analytical method |
| 06/02/2009 | US7541474 Catalyzed process of making C-5-substituted heterocyclic inhibitors of 11β-hydroxy steroid dehydrogenase type 1 |
| 06/02/2009 | US7541472 3-Aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides |
| 06/02/2009 | US7541356 Compounds for use in weight loss and appetite suppression in humans |
| 05/28/2009 | WO2009067663A1 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds |
| 05/28/2009 | WO2009067618A1 Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | WO2009067604A1 Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders |
| 05/28/2009 | WO2009066060A2 4-substituted-6-isopropyl-benzene-1,3-diol compounds and their use |
| 05/28/2009 | WO2009049180A3 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
| 05/28/2009 | WO2009032294A3 Processes for the preparation of a linezolid intermediate, linezolid hydroxide |
| 05/28/2009 | US20090137817 Spatially-defined macrocyclic compounds useful for drug discovery |
| 05/28/2009 | US20090137611 Fungicide N-Cyclopropyl-Sulfonylamide Derivatives |
| 05/28/2009 | US20090137596 G-protein inhibitor |
| 05/28/2009 | US20090137585 N-acylsulfonamide apoptosis promoters |
| 05/28/2009 | US20090137548 1,3-Oxazolidin-2-One Derivatives Useful as Cetp Inhibitors |
| 05/28/2009 | US20090137453 Composition comprising at least one oxazoline to inhibit migration of langerhans cells, and uses thereof |
| 05/28/2009 | US20090137420 Methods, compounds and compositions with genotype selective anticancer activity |
| 05/28/2009 | US20090136448 Antiviral 2-Carboxy-Thiophene Compounds |
| 05/28/2009 | CA2722591A1 Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | CA2722586A1 Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders |